Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases

Saved in:
Bibliographic Details
Published in:MD conference express 2007-08, Vol.7 (3), p.14-15
Main Authors: Helwick, C., Nordlinger, N.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1559-8977
2155-756X
DOI:10.1177/155989770700700307